Article
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Oncotarget - 22 Sept 2015
Bizzarro Valentina, Belvedere Raffaella, Milone Maria Rita, Pucci Biagio, Lombardi Rita, Bruzzese Francesca, Popolo Ada, Parente Luca, Budillon Alfredo, Petrella Antonello
Abstract excerpt
In this study, we have characterized the role of annexin A1 (ANXA1) in the acquisition and maintenance of stem-like/aggressive features in prostate cancer (PCa) cells comparing zoledronic acid (ZA)-resistant DU145R80 with their parental DU145 cells. ANXA1 is over-expressed in DU145R80 cells and its down-regulation abolishes their resistance to ZA. Moreover, ANXA1 induces DU145 and DU145R80 invasiveness acting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
